Heidi Yoder Pixley
Papers
1
Total Citations
4
H-Index
1
About
Heidi Yoder Pixley is a leading researcher in virology and vaccine development, with a specialized focus on dengue fever—a disease threatening half the global population. Her work centers on advancing live-attenuated tetravalent dengue vaccines, which are critical for preventing this mosquito-borne illness. Pixley’s major contribution is the development of a fully automated high-throughput immuno-µPlaque assay, detailed in her 2024 paper, which has already garnered 4 citations. This innovative method streamlines the quantification of live virus vaccines, replacing labor-intensive manual techniques with a scalable, precise platform that accelerates vaccine testing and quality control. By enhancing the efficiency of vaccine development, Pixley’s work directly addresses the urgent need for effective dengue prevention, particularly in endemic regions. Her achievements include pioneering automation in virological assays, which reduces human error and increases throughput—a vital step toward global vaccine accessibility. Pixley’s research not only advances dengue vaccine science but also sets a precedent for high-throughput methods in live-attenuated vaccine production, making her a key figure in combating one of the world’s most persistent infectious diseases.
Research Focus
Key Achievements
Top Papers
- 1